CN Patent

CN113827576B — 一种活性成分为草酸纳洛解的药物组合物及制备方法

Assigned to Beijing Shangxiutang Pharmaceutical Technology Co ltd · Expires 2023-08-01 · 3y expired

What this patent protects

本发明提供了一种活性成分为草酸纳洛解的药物组合物及制备方法，以一定粒度6α型草酸纳洛解作为制剂原料，采用分步混合的方式克服草酸纳洛解粘涩导致混合不均一的问题，采用粉末直压工艺将其制备成片并进行包衣，具有工艺简单、快速溶出和优越的稳定性。

USPTO Abstract

本发明提供了一种活性成分为草酸纳洛解的药物组合物及制备方法，以一定粒度6α型草酸纳洛解作为制剂原料，采用分步混合的方式克服草酸纳洛解粘涩导致混合不均一的问题，采用粉末直压工艺将其制备成片并进行包衣，具有工艺简单、快速溶出和优越的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN113827576B
Jurisdiction
CN
Classification
—
Expires
2023-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Shangxiutang Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.